DK0590355T3 - Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter - Google Patents

Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter

Info

Publication number
DK0590355T3
DK0590355T3 DK93114235.0T DK93114235T DK0590355T3 DK 0590355 T3 DK0590355 T3 DK 0590355T3 DK 93114235 T DK93114235 T DK 93114235T DK 0590355 T3 DK0590355 T3 DK 0590355T3
Authority
DK
Denmark
Prior art keywords
carnitine
acyl
aids
patients
carnitines
Prior art date
Application number
DK93114235.0T
Other languages
English (en)
Inventor
Simone Claudio Dr De
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0590355T3 publication Critical patent/DK0590355T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK93114235.0T 1992-09-24 1993-09-06 Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter DK0590355T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920693A IT1258491B (it) 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.

Publications (1)

Publication Number Publication Date
DK0590355T3 true DK0590355T3 (da) 1998-03-02

Family

ID=11401203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114235.0T DK0590355T3 (da) 1992-09-24 1993-09-06 Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter

Country Status (11)

Country Link
US (1) US5631288A (da)
EP (1) EP0590355B1 (da)
JP (1) JPH06227983A (da)
KR (1) KR0136559B1 (da)
AT (1) ATE160090T1 (da)
DE (1) DE69315162T2 (da)
DK (1) DK0590355T3 (da)
ES (1) ES2110551T3 (da)
GR (1) GR3025372T3 (da)
IT (1) IT1258491B (da)
ZA (1) ZA936300B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6922994A (en) * 1993-06-21 1995-01-17 Bernardini, Attilio Use of acylcarnitin to treat illnesses caused by aids
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20080119386A1 (en) * 2006-11-22 2008-05-22 Carl Germano Nutritional formula for athletes' recovery
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) * 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease

Also Published As

Publication number Publication date
KR940006576A (ko) 1994-04-25
ITRM920693A1 (it) 1994-03-24
EP0590355A1 (en) 1994-04-06
DE69315162T2 (de) 1998-03-12
HK1004910A1 (en) 1998-12-11
EP0590355B1 (en) 1997-11-12
GR3025372T3 (en) 1998-02-27
ZA936300B (en) 1995-02-27
KR0136559B1 (ko) 1998-04-25
ES2110551T3 (es) 1998-02-16
US5631288A (en) 1997-05-20
ATE160090T1 (de) 1997-11-15
IT1258491B (it) 1996-02-26
JPH06227983A (ja) 1994-08-16
DE69315162D1 (de) 1997-12-18
ITRM920693A0 (it) 1992-09-24

Similar Documents

Publication Publication Date Title
DK275488A (da) Indolonderivater
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
DK198791D0 (da) Terapeutiske kombinationer af 3'-azido-3'-desoxythymidin og andre terapeutiske midler
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
DK0658110T3 (da) Anvendelse af norastemizol til behandling af allergisk rhinitis
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
GR3025372T3 (en) Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients
ATE135909T1 (de) Verfahren zur behandlung von akne
DK174389D0 (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
DK347289A (da) Terapeutiske forbindelser
AU670491C (en) Pharmaceutical for the treatment of skin disorders
LU90791I2 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
DK0561597T3 (da) Physostigminderivater, deres anvendelse og farmaceutiske præparater indeholdende disse
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
NO923198L (no) Terapeutiske midler
IL100637A0 (en) Salts of 2-(2,6-dichloroanilino)-phenylacetic acid,a process for their preparation and their use for pharmaceutical preparation to be applied locally
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
JPS6442434A (en) Gepilone for alleviating fright trouble
ES8500055A1 (es) Procedimiento para la obtencion de un medicamento a base de un derivado de pirazolinona.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
IT9067177A0 (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno